{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:19:15Z","timestamp":1792880355254,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"am","delay-in-days":281,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100016161","name":"Just Beginnings Collaborative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY003790"],"award-info":[{"award-number":["P30EY003790"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1K08EY019686-01"],"award-info":[{"award-number":["1K08EY019686-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012489","name":"Boston Area Diabetes Endocrinology Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM 073263"],"award-info":[{"award-number":["GM 073263"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.biomaterials.2019.119285","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T20:24:39Z","timestamp":1561062279000},"page":"119285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"C","title":["Topical sustained drug delivery to the retina with a drug-eluting contact lens"],"prefix":"10.1016","volume":"217","author":[{"given":"Amy E.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokendrakumar C.","family":"Bengani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehka","family":"Tulsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Maidana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Salvador-Culla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenaga","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi E.","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koli","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangju","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios G.","family":"Vavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kohane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Ciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.biomaterials.2019.119285_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4239\/wjd.v7.i16.333","article-title":"Treatment of diabetic retinopathy: recent advances and unresolved challenges","volume":"7","author":"Stewart","year":"2016","journal-title":"World J. Diabetes"},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119285_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.biomaterials.2019.119285_bib3","article-title":"Loss to follow-up after intravitreal AntieVascular endothelial growth factor injections in patients with diabetic macular edema","author":"Gao","year":"2018","journal-title":"Ophthalmology Retina"},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119285_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jamaophthalmol.2018.3578","article-title":"Loss to follow-up among patients with neovascular age-related macular degeneration who received intravitreal anti-vascular endothelial growth factor injections","volume":"136","author":"Obeid","year":"2018","journal-title":"JAMA Ophthalmol."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119285_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/09273948.2016.1184284","article-title":"Common and rare ocular side-effects of the dexamethasone implant","volume":"25","author":"Fassbender Adeniran","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","article-title":"Intraocular pressure monitoring post intravitreal steroids: a systematic review","volume":"58","author":"Kiddee","year":"2013","journal-title":"Surv. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.eye.6701895","article-title":"Corticosteroid-induced glaucoma: a review of the literature","volume":"20","author":"Kersey","year":"2006","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1872211308666140130093301","article-title":"Drug delivery to the back of the eye following topical administration: an update on research and patenting activity","volume":"8","author":"Boddu","year":"2014","journal-title":"Recent Pat. Drug Deliv. Formulation"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119285_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.31083\/ph.2008.7322","article-title":"Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations","volume":"63","author":"Loftsson","year":"2008","journal-title":"Pharmazie"},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119285_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11095-018-2519-x","article-title":"Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation","volume":"35","author":"Rodrigues","year":"2018","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"14","key":"10.1016\/j.biomaterials.2019.119285_bib11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119285_bib12","first-page":"961","article-title":"Drug delivery for posterior segment eye disease","volume":"41","author":"Geroski","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biomaterials.2019.119285_bib13","series-title":"Ocular Absorption Following Topical Delivery. Advanced Drug Delivery Reviews","author":"J\u00e4rvinen","year":"1995"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119285_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.2042-7158.1986.tb04611.x","article-title":"A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man","volume":"38","author":"Zaki","year":"1986","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2003.12.009","article-title":"Determinants of eye drop size","volume":"49","author":"Van Santvliet","year":"2004","journal-title":"Surv. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/02713683.2017.1418893","article-title":"Measurement of the retention time of different ophthalmic formulations with ultrahigh-resolution optical coherence tomography","volume":"43","author":"Gagliano","year":"2018","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0975-7406.149810","article-title":"An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention","volume":"7","author":"Gupta","year":"2015","journal-title":"J. Pharm. BioAllied Sci."},{"key":"10.1016\/j.biomaterials.2019.119285_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lfs.2018.09.050","article-title":"Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: in vitro characterization, in vivo pharmacokinetics and pharmacodynamics study","volume":"212","author":"Zeng","year":"2018","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119285_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/02713688809031801","article-title":"Comparison of conjunctival and corneal surface areas in rabbit and human","volume":"7","author":"Watsky","year":"1988","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.optom.2014.12.001","article-title":"Tear exchange and contact lenses: a review","volume":"8","author":"Muntz","year":"2015","journal-title":"J. Opt."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119285_bib22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425247.2013.821462","article-title":"Contact lenses as a platform for ocular drug delivery","volume":"10","author":"Bengani","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119285_bib23","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling ophthalmic drug delivery by soaked contact lenses","volume":"45","author":"Li","year":"2006","journal-title":"Ind. Eng. Chem. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119285_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/08820530902802161","article-title":"Contact lenses for drug delivery","volume":"24","author":"Ciolino","year":"2009","journal-title":"Semin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ICL.0b013e31827d4f25","article-title":"Uptake and release phenomena in contact lens care by silicone hydrogel lenses","volume":"39","author":"Jones","year":"2013","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119285_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archopht.1974.01010010425011","article-title":"Ocular penetration of prednisolone and the hydrophilic contact lens","volume":"92","author":"Hull","year":"1974","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0896-1549(02)00066-4","article-title":"The evolution in therapeutic contact lenses","volume":"16","author":"Shah","year":"2003","journal-title":"Ophthal. Mol. Clin. North Am."},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119285_bib28","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1167\/iovs.08-2826","article-title":"A drug-eluting contact lens","volume":"50","author":"Ciolino","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biomaterials.2013.09.032","article-title":"In vivo performance of a drug-eluting contact lens to treat glaucoma for a month","volume":"35","author":"Ciolino","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2019.119285_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2016.06.038","article-title":"Latanoprost-eluting contact lenses in glaucomatous monkeys","author":"Ciolino","year":"2016","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119285_bib31","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1167\/iovs.10-6935","article-title":"A prototype antifungal contact lens","volume":"52","author":"Ciolino","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119285_bib32","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3390\/ijms19092830","article-title":"Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application","volume":"19","author":"Tsai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119285_bib33","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.biomaterials.2019.119285_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJN.S6428","article-title":"Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits","volume":"4","author":"Zhang","year":"2009","journal-title":"Int. J. Nanomed."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119285_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2013.12.020","article-title":"Polymeric delivery systems for dexamethasone","volume":"96","author":"Urba\u0144ska","year":"2014","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.11.028","article-title":"Encapsulation of dexamethasone into biodegradable polymeric nanoparticles","volume":"331","author":"G\u00f3mez-Gaete","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","article-title":"Evaluation of in vivo\u2013in vitro release of dexamethasone from PLGA microspheres","volume":"127","author":"Zolnik","year":"2008","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119285_bib38","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/bm300520u","article-title":"Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response","volume":"13","author":"Vacanti","year":"2012","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00006324-198701000-00006","article-title":"Visual field loss with colored hydrogel lenses","volume":"64","author":"Josephson","year":"1987","journal-title":"Am. J. Optom. Physiol. Opt."},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119285_bib40","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/archopht.1988.01060140852025","article-title":"Visual field constriction caused by colored contact lenses","volume":"106","author":"Insler","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biomaterials.2019.119285_bib41","first-page":"2259","article-title":"Polylactic-co-glycolic acid (PLGA)","author":"Avgoustakis","year":"2008","journal-title":"Encycl. Biomater. Biomed. Eng."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1444-0938.2010.00553.x","article-title":"Drug delivery to the posterior segment of the eye through hydrogel contact lenses","volume":"94","author":"Schultz","year":"2011","journal-title":"Clin. Exp. Optom."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119285_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00124-8","article-title":"In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials","volume":"257","author":"Karlgard","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119285_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICL.0b013e3181b26c49","article-title":"Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses","volume":"35","author":"Boone","year":"2009","journal-title":"Eye Contact Lens"},{"issue":"8","key":"10.1016\/j.biomaterials.2019.119285_bib45","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archopht.1996.01100140208016","article-title":"Corticosteroid therapy of eye disease. Fifty years later","volume":"114","author":"Raizman","year":"1996","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119285_bib46","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archopht.1989.01070020445052","article-title":"Collagen shield enhancement of topical dexamethasone penetration","volume":"107","author":"Hwang","year":"1989","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119285_bib48","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1248\/cpb.52.1290","article-title":"A pharmacokinetic model for ocular drug delivery","volume":"52","author":"Tojo","year":"2004","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119285_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.31083\/ph.2008.7322","article-title":"Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations","volume":"63","author":"Loftsson","year":"2008","journal-title":"Pharmazie"},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","article-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood\u2013retinal and blood\u2013aqueous barrier breakdown","volume":"80","author":"Edelman","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib52","first-page":"46","article-title":"An experimental model of preretinal neovascularization in the rabbit","volume":"32","author":"Antoszyk","year":"1991","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119285_bib53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.63.9.646","article-title":"Ocular changes in rabbits with corticosteroid-induced ocular hypertension","volume":"63","author":"Ticho","year":"1979","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119285_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/jop.1987.3.185","article-title":"Steroid-induced ocular hypertension in the rabbit: a model using subconjunctival injections","volume":"3","author":"Hester","year":"1987","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.biomaterials.2019.119285_bib55","series-title":"Report of the National Eye Institute\/Industry Workshop on Clinical Trials in Dry Eyes","first-page":"221","author":"Lemp","year":"1995"},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119285_bib56","first-page":"1161","article-title":"Critical oxygen levels to avoid corneal edema for daily and extended wear contact lenses","volume":"25","author":"Holden","year":"1984","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib57","first-page":"12","article-title":"Physiologic changes of the cornea with contact lens wear","volume":"28","author":"Liesegang","year":"2002","journal-title":"CLAO J."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119285_bib58","first-page":"828","article-title":"A closed eye contact lens model of corneal inflammation. Part 1: increased synthesis of cytochrome P450 arachidonic acid metabolites","volume":"36","author":"Conners","year":"1995","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/ceyr.23.1.1.5422","article-title":"Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear","volume":"23","author":"Mastyugin","year":"2001","journal-title":"Curr. Eye Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119285_bib60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bjo.76.11.681","article-title":"Pharmacokinetics of ophthalmic corticosteroids","volume":"76","author":"McGhee","year":"1992","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib61","first-page":"841","article-title":"Response of rabbits to corticosteroids. I. Influence on growth, intraocular pressure and lens transparency","volume":"63","author":"Wood","year":"1967","journal-title":"AJOPHT"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib62","first-page":"849","article-title":"Response of rabbits to corticosteroids. II. Influence of topical therapy on lens, aqueous humor, serum and urine composition","volume":"63","author":"Wood","year":"1967","journal-title":"AJOPHT"},{"key":"10.1016\/j.biomaterials.2019.119285_bib63","first-page":"492","article-title":"The side effects of corticosteroids","volume":"3","author":"Becker","year":"1964","journal-title":"Investig. Ophthalmol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib64","first-page":"192","article-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection","volume":"128","author":"Weijtens","year":"1999","journal-title":"AJOPHT"},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119285_bib65","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0161-6420(02)01176-4","article-title":"Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate","volume":"109","author":"Weijtens","year":"2002","journal-title":"OPHTHA"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib66","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3928\/1081-597X-20000701-07","article-title":"Topical tetracaine with bandage soft contact lens pain control after photorefractive keratectomy","volume":"16","author":"Brilakis","year":"2000","journal-title":"J. Refract. Surg."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.ICL.0000107181.42704.D8","article-title":"Therapeutic use of a lotrafilcon A silicone hydrogel soft contact lens as a bandage after LASEK surgery","volume":"30","author":"Szaflik","year":"2004","journal-title":"Eye Contact Lens"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119285_bib68","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0161-6420(95)30926-8","article-title":"Controlled evaluation of a bandage contact lens and a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal abrasions","volume":"102","author":"Donnenfeld","year":"1995","journal-title":"OPHTHA"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119285_bib69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/02713680600719036","article-title":"Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes","volume":"31","author":"Fialho","year":"2006","journal-title":"Curr. Eye Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119285_bib70","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1755-3768.2010.02016.x","article-title":"A rabbit model of age\u2010dependant ocular hypertensive response to topical corticosteroids","volume":"90","author":"Qin","year":"2012","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib71","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"Ghate","year":"2008","journal-title":"J. Glaucoma"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119285_bib72","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1600-0420.2007.00885.x","article-title":"Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye","volume":"85","author":"Sigurdsson","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119285_bib73","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1167\/iovs.11-8178","article-title":"Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema","volume":"52","author":"Tanito","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2019.119285_bib74","doi-asserted-by":"crossref","first-page":"e689","DOI":"10.1111\/aos.12560","article-title":"Topical dexamethasone-cyclodextrin microparticle eye drops for uveitic macular oedema","volume":"92","author":"Krag","year":"2014","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119285_bib75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/aos.12744","article-title":"Topical dexamethasone-cyclodextrin nanoparticle eye drops for non-infectious Uveitic macular oedema and vitritis - a pilot study","volume":"93","author":"Shulman","year":"2015","journal-title":"Acta Ophthalmol."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119285_bib76","doi-asserted-by":"crossref","first-page":"TFOS98","DOI":"10.1167\/iovs.13-13187","article-title":"The TFOS international workshop on contact lens discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee","volume":"54","author":"Efron","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119285_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1001\/archopht.1970.00990030005003","article-title":"Corneal swelling caused by contact lens wear","volume":"83","author":"Mandell","year":"1970","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119285_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000050858","article-title":"Effects of contact lenses on corneal endothelium\u2013a morphological and functional study","volume":"215","author":"Chang","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.biomaterials.2019.119285_bib79","first-page":"346","article-title":"Contact lens-induced edema in vitro","volume":"32","author":"Huff","year":"1991","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119285_bib80","first-page":"357","article-title":"Effect of dexamethasone on corneal endothelial function in Fuchs' dystrophy","volume":"29","author":"Wilson","year":"1988","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib81","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archopht.1968.03850040368003","article-title":"Corneal thickness after topical corticosteroid therapy","volume":"79","author":"Baum","year":"1968","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib82","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0014-4835(70)80042-2","article-title":"Effect of topical application of hydrocortisone on the corneal thickness","volume":"10","author":"Hara","year":"1970","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119285_bib83","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01739643","article-title":"Effect of corticosteroids on healing of the corneal endothelium in cats","volume":"235","author":"Solomon","year":"1997","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biomaterials.2019.119285_bib84","unstructured":"Wilson SE, Bourne WM, Brubaker RF Effect of dexamethasone on corneal endothelial function in Fuchs' dystrophy. Investig. Ophthalmol. Vis. Sci. 29(3):357\u2013361."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib85","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0014-4835(70)80042-2","article-title":"Effect of topical application of hydrocortisone on the corneal thickness","volume":"10","author":"Hara","year":"1970","journal-title":"Exp. Eye Res."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2019.119285_bib86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejphar.2007.12.033","article-title":"Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch","volume":"583","author":"Malcher-Lopes","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biomaterials.2019.119285_bib87","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2147\/OPTH.S28083","article-title":"Dendritic immune cell densities in the central cornea associated with soft contact lens types and lens care solution types: a pilot study","volume":"6","author":"Sindt","year":"2012","journal-title":"Clin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119285_bib88","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clae.2016.02.008","article-title":"Changes in corneal Langerhans cell density during the first few hours of contact lens wear","volume":"39","author":"Alzahrani","year":"2016","journal-title":"Contact Lens Anterior Eye"},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119285_bib89","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1167\/iovs.14-14386","article-title":"CD147 required for corneal endothelial lactate transport","volume":"55","author":"Li","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2019.119285_bib90","first-page":"1093","article-title":"Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye","volume":"26","author":"Knepper","year":"1985","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biomaterials.2019.119285_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.exer.2015.06.002","article-title":"Animal models of glucocorticoid-induced glaucoma","volume":"141","author":"Overby","year":"2015","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib92","first-page":"114","article-title":"The effects of ophthalmic solutions on the transmission of light through hydrogel lenses","volume":"16","author":"Bergen","year":"1990","journal-title":"CLAO J."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119285_bib93","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1463-5224.2012.01041.x","article-title":"White-to-white corneal diameter, pupil diameter, central corneal thickness and thinnest corneal thickness values of emmetropic subjects","volume":"16","author":"Wang","year":"2013","journal-title":"Vet. Ophthalmol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219303849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219303849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:00:37Z","timestamp":1777485637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961219303849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":93,"alternative-id":["S0142961219303849"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119285","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical sustained drug delivery to the retina with a drug-eluting contact lens","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"119285"}}